Maze Therapeutics MAZE
NASDAQ MAZE
$26.43 -0.22 (-0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Return on Sales [ROS] (2024 - 2026)

Updated

Maze Therapeutics (MAZE) reported Return on Sales [ROS] of -728.06% for Q2 2026, up 4305.14 percentage points from -5033.20% a year earlier but down 595.30 percentage points from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Return on Sales [ROS] (2024 - 2026) Analysis & Trends

For FY2024, Maze Therapeutics posted Return on Sales [ROS] of 34.38%.

  • Five-year quarterly Return on Sales [ROS] spans a low of -5033.20% in Q2 2025 and a high of 84.58% in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Maze Therapeutics 1.47 Bn 1.47 Bn - -728.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -728.06%
Mar 31, 2026 -132.77%
Jun 30, 2025 -5,033.20%
Mar 31, 2025 29.97%
Sep 30, 2024 -969.16%
Jun 30, 2024 84.58%
API Access

Maze Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MAZE&period=max&api_key=YOUR_API_KEY